US 11976109
Neutralizing antibodies to ebola virus glycoprotein and their use
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11976109 (Neutralizing antibodies to ebola virus glycoprotein and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K48/005, A61P